Psychedelics UBC graduates launch promising psychedelics startup in Nevada Married couple now run state-of-the-art laboratory in Las Vegas dedicated to advancing new therapies Rowan DunneJuly 8, 2022
Psychedelics Nirvana Life acquires exclusive license for novel psychedelic delivery system Canadian life sciences outfit continues to push the envelope in the clinical psychedelic sector Rowan DunneJuly 6, 2022
Psychedelics PSYC Corp makes successful psychedelic investments Company stock portfolio appreciates significantly since January 2021 Rowan DunneJuly 5, 2022
Psychedelics MAPS has immense fundraising success Christie's helps psychedelic research group generate unprecedented revenue via crypto-asset art auction Rowan DunneJuly 4, 2022
Psychedelics Mindset Pharma develops patent-pending new technology Company announces development of novel intranasal formulation with promising efficacy Rowan DunneJune 30, 2022
Alternative Energy Cybin receives FDA approval for new in-human clinical trial Patient enlistment for new study to treat Major Depressive Disorder set to begin promptly Rowan DunneJune 28, 2022
Psychedelics Numinus to offer ketamine-assisted psychotherapy B.C. Mental health care company develops passion inspired by Utah pioneers Rowan DunneJune 27, 2022
Psychedelics HAVN Life to make July appearance on renowned documentary series Biotechnology outfit set to receive attention on American TV this summer Rowan DunneJune 24, 2022
Psychedelics Nirvana Life Sciences boasts new patent for innovative psychedelic compound Company isolates 4-PO-Psilocin into biologically active salt with 99% purity ratio Rowan DunneJune 23, 2022
Medical and Pharmaceutical InMed Pharmaceuticals publicizes new peer-reviewed study New academic journal spotlights potential for rare cannabinoids to treat skin conditions Rowan DunneJune 20, 2022